Synopsys, Inc. $SNPS Stock: Fifth Third Bancorp Lowers Stake

Fifth Third Bancorp reduced its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 4.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 158,521 shares of the semiconductor company’s stock after selling 6,855 shares during the quarter. Fifth Third Bancorp owned 0.08% of Synopsys worth $68,947,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of SNPS. BlackRock Inc. bought a new stake in Synopsys during the 2nd quarter worth approximately $7,228,099,000. Van ECK Associates Corp raised its holdings in Synopsys by 19.7% during the 2nd quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company’s stock worth $1,542,175,000 after buying an additional 569,687 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Synopsys by 40.7% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,087,349 shares of the semiconductor company’s stock valued at $1,377,174,000 after buying an additional 892,736 shares in the last quarter. Assenagon Asset Management S.A. lifted its stake in Synopsys by 11.2% in the third quarter. Assenagon Asset Management S.A. now owns 2,729,988 shares of the semiconductor company’s stock valued at $1,187,381,000 after buying an additional 274,586 shares in the last quarter. Finally, Amundi lifted its stake in Synopsys by 3.6% in the first quarter. Amundi now owns 1,761,983 shares of the semiconductor company’s stock valued at $698,591,000 after buying an additional 61,077 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Key Synopsys News

Here’s some of the latest news about SNPS:

• Positive Sentiment: Commentary highlights Synopsys’ recent run of earnings beats and its strategic role in the AI chip ecosystem, where chip designers rely on EDA software. That backdrop supports the long-term growth case, although it has not prevented recent share-price weakness. The AI Chip Race Is Getting Crowded. This Company Has Another Advantage
• Neutral Sentiment: One article frames Synopsys’ earnings strength against a cautious market tape, suggesting solid company fundamentals are not yet translating into consistently positive investor sentiment. Synopsys (SNPS) Stock Price Prediction: Earnings strength meets a cautious tape
• Negative Sentiment: Despite estimate beats, Synopsys shares have reportedly struggled to hold post-earnings gains. Coverage identifies debt and upcoming guidance as investor concerns ahead of the December earnings report, which could keep the shares volatile. Synopsys at $460: Appealing Ahead of Dec. 8 Earnings

Insider Buying and Selling at Synopsys

In other Synopsys news, CFO Sudhindra Kankanwadi sold 9,170 shares of the business’s stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the sale, the chief financial officer directly owned 22,717 shares of the company’s stock, valued at $11,358,500. The trade was a 28.76% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Aart de Geus sold 25,000 shares of the stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $441.76, for a total transaction of $11,044,000.00. Following the transaction, the insider owned 120,421 shares of the company’s stock, valued at approximately $53,197,180.96. This represents a 17.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 117,163 shares of company stock worth $51,366,457 in the last three months. 0.56% of the stock is currently owned by company insiders.

Synopsys Trading Up 0.1%

NASDAQ SNPS opened at $462.69 on Friday. Synopsys, Inc. has a 52 week low of $362.55 and a 52 week high of $539.48. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. The stock’s 50 day moving average price is $444.38 and its two-hundred day moving average price is $441.35. The stock has a market capitalization of $88.67 billion, a price-to-earnings ratio of 46.96, a PEG ratio of 1.47 and a beta of 1.18.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. The company had revenue of $2.48 billion for the quarter, compared to the consensus estimate of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The firm’s revenue was up 42.4% compared to the same quarter last year. During the same period last year, the company earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, analysts anticipate that Synopsys, Inc. will post 11.01 earnings per share for the current fiscal year.

Synopsys announced that its board has initiated a stock repurchase program on Monday, October 5th that authorizes the company to buy back $1 billion in outstanding shares. This buyback authorization authorizes the semiconductor company to purchase up to 1.1% of its shares through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its stock is undervalued.

Analysts Set New Price Targets

SNPS has been the subject of several research analyst reports. UBS Group set a $570.00 price target on shares of Synopsys in a report on Thursday, August 27th. HSBC lowered shares of Synopsys from a “buy” rating to a “reduce” rating in a report on Friday, September 25th. Barclays started coverage on shares of Synopsys in a research report on Friday, September 25th. They issued an “overweight” rating on the stock. Rothschild & Co Redburn reduced their target price on shares of Synopsys from $560.00 to $550.00 and set a “buy” rating for the company in a research note on Wednesday, September 23rd. Finally, KeyCorp increased their target price on Synopsys from $600.00 to $605.00 and gave the stock an “overweight” rating in a report on Thursday, October 1st. One investment analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $575.00.

Synopsys Company Profile

Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.